DNLI Annual Cash & Cash Equivalents
$127.11 M
-$90.94 M-41.71%
31 December 2023
Summary:
As of January 23, 2025, DNLI annual cash & cash equivalents is $127.11 million, with the most recent change of -$90.94 million (-41.71%) on December 31, 2023. During the last 3 years, it has fallen by -$380.04 million (-74.94%). DNLI annual cash & cash equivalents is now -74.94% below its all-time high of $507.14 million, reached on December 31, 2020.DNLI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DNLI Quarterly Cash And Cash Equivalents
$90.64 M
+$15.96 M+21.37%
30 September 2024
Summary:
As of January 23, 2025, DNLI quarterly cash and cash equivalents is $90.64 million, with the most recent change of +$15.96 million (+21.37%) on September 30, 2024. Over the past year, it has increased by +$15.96 million (+21.37%). DNLI quarterly cash and cash equivalents is now -82.13% below its all-time high of $507.14 million, reached on December 31, 2020.DNLI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DNLI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.7% | +21.4% |
| 3 y3 years | -74.9% | -58.4% |
| 5 y5 years | +64.8% | -58.4% |
DNLI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.7% | at low | -69.1% | +49.6% |
| 5 y | 5-year | -74.9% | +60.0% | -82.1% | +49.6% |
| alltime | all time | -74.9% | +313.5% | -82.1% | +173.9% |
Denali Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $90.64 M(+21.4%) |
| June 2024 | - | $74.68 M(+23.3%) |
| Mar 2024 | - | $60.57 M(-52.3%) |
| Dec 2023 | $127.11 M(-41.7%) | $127.11 M(-14.1%) |
| Sept 2023 | - | $148.01 M(+12.2%) |
| June 2023 | - | $131.97 M(+93.7%) |
| Mar 2023 | - | $68.13 M(-68.8%) |
| Dec 2022 | $218.04 M(-25.7%) | $218.04 M(+83.8%) |
| Sept 2022 | - | $118.61 M(-23.5%) |
| June 2022 | - | $155.09 M(+47.8%) |
| Mar 2022 | - | $104.95 M(-64.2%) |
| Dec 2021 | $293.48 M(-42.1%) | $293.48 M(-25.6%) |
| Sept 2021 | - | $394.55 M(-18.8%) |
| June 2021 | - | $485.68 M(+11.6%) |
| Mar 2021 | - | $435.32 M(-14.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $507.14 M(+538.3%) | $507.14 M(+44.5%) |
| Sept 2020 | - | $351.05 M(+155.9%) |
| June 2020 | - | $137.18 M(-33.9%) |
| Mar 2020 | - | $207.54 M(+161.2%) |
| Dec 2019 | $79.45 M(+3.0%) | $79.45 M(-3.9%) |
| Sept 2019 | - | $82.67 M(+31.4%) |
| June 2019 | - | $62.94 M(+58.7%) |
| Mar 2019 | - | $39.66 M(-48.6%) |
| Dec 2018 | $77.12 M(-64.7%) | $77.12 M(+76.7%) |
| Sept 2018 | - | $43.65 M(+31.9%) |
| June 2018 | - | $33.09 M(-24.8%) |
| Mar 2018 | - | $44.00 M(-79.9%) |
| Dec 2017 | $218.38 M(+448.0%) | $218.38 M(+502.1%) |
| Sept 2017 | - | $36.27 M(-9.0%) |
| Dec 2016 | $39.85 M(+29.6%) | $39.85 M |
| Dec 2015 | $30.74 M | - |
FAQ
- What is Denali Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Denali Therapeutics?
- What is Denali Therapeutics annual cash & cash equivalents year-on-year change?
- What is Denali Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Denali Therapeutics?
- What is Denali Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Denali Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DNLI is $127.11 M
What is the all time high annual cash & cash equivalents for Denali Therapeutics?
Denali Therapeutics all-time high annual cash & cash equivalents is $507.14 M
What is Denali Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DNLI annual cash & cash equivalents has changed by -$90.94 M (-41.71%)
What is Denali Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DNLI is $90.64 M
What is the all time high quarterly cash and cash equivalents for Denali Therapeutics?
Denali Therapeutics all-time high quarterly cash and cash equivalents is $507.14 M
What is Denali Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DNLI quarterly cash and cash equivalents has changed by +$15.96 M (+21.37%)